Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
2021 Second quarter results announcement
We will announce our second quarter 2021 results at 12:00 BST, 07:00 EDT on Wednesday 28 July.
Following the announcement there will be a webcast hosted by Emma Walmsley, CEO and other members of CET at 14:00 BST, 09:00 EDT.
Latest information
Latest press releases
- Shingrix approved in the US for prevention of shingles in immunocompromised adults
- Brian McNamara appointed CEO Designate of new independent Consumer Healthcare company
- ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of regimens of at least 3 drugs
New GSK Investor update
Emma Walmsley, CEO, and other members of CET hosted a virtual investor update on Wednesday 23 June.
The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.
Annual Report 2020
We published our Annual Report 2020 on 09 March 2021. View the summary and download the full report or individual sections.
Sign up for announcements
Sign up to receive email notifications when we publish a stock exchange announcement.